Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers

Amar Singh, Richard F. Jones, Henry Friedman, Shahendeh Hathir, G. Soós, Andras Zabo, Gabriel P. Haas

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Evidence has been presented that tumor suppressor genes p53 and Rb play a crucial role in the development of both human prostate and bladder cancer. Patients with either cancer are at an increased risk for developing the other malignancy as compared to the general population. The purpose of the present study was to investigate whether there is abnormal expression of these two suppressor proteins in both the bladder and prostate cancers of the same patient. The expression of p53 and pRb in bladder and prostate cancer specimens obtained from 15 patients having both cancers was studied using immunohistochemical staining with antibodies against these proteins. The expression of p53 and pRb in both bladder and prostate cancers of the same patient was congruent in 8 of 15 cases (53%) for p53 and 9 of 15 cases (60%) for pRb. The significance of these findings warrants further investigations.

Original languageEnglish
Pages (from-to)5415-5417
Number of pages3
JournalAnticancer Research
Volume19
Issue number6 B
Publication statusPublished - Nov 1999

Fingerprint

Urinary Bladder Neoplasms
Prostatic Neoplasms
Neoplasms
Human Development
Tumor Suppressor Genes
Proteins
Staining and Labeling
Antibodies
Population

Keywords

  • Bladder cancer
  • p53
  • pRb
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Singh, A., Jones, R. F., Friedman, H., Hathir, S., Soós, G., Zabo, A., & Haas, G. P. (1999). Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Research, 19(6 B), 5415-5417.

Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. / Singh, Amar; Jones, Richard F.; Friedman, Henry; Hathir, Shahendeh; Soós, G.; Zabo, Andras; Haas, Gabriel P.

In: Anticancer Research, Vol. 19, No. 6 B, 11.1999, p. 5415-5417.

Research output: Contribution to journalArticle

Singh, A, Jones, RF, Friedman, H, Hathir, S, Soós, G, Zabo, A & Haas, GP 1999, 'Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers', Anticancer Research, vol. 19, no. 6 B, pp. 5415-5417.
Singh A, Jones RF, Friedman H, Hathir S, Soós G, Zabo A et al. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Research. 1999 Nov;19(6 B):5415-5417.
Singh, Amar ; Jones, Richard F. ; Friedman, Henry ; Hathir, Shahendeh ; Soós, G. ; Zabo, Andras ; Haas, Gabriel P. / Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. In: Anticancer Research. 1999 ; Vol. 19, No. 6 B. pp. 5415-5417.
@article{c3d753ed81ba49f4bd277ba6ca3f07ae,
title = "Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers",
abstract = "Evidence has been presented that tumor suppressor genes p53 and Rb play a crucial role in the development of both human prostate and bladder cancer. Patients with either cancer are at an increased risk for developing the other malignancy as compared to the general population. The purpose of the present study was to investigate whether there is abnormal expression of these two suppressor proteins in both the bladder and prostate cancers of the same patient. The expression of p53 and pRb in bladder and prostate cancer specimens obtained from 15 patients having both cancers was studied using immunohistochemical staining with antibodies against these proteins. The expression of p53 and pRb in both bladder and prostate cancers of the same patient was congruent in 8 of 15 cases (53{\%}) for p53 and 9 of 15 cases (60{\%}) for pRb. The significance of these findings warrants further investigations.",
keywords = "Bladder cancer, p53, pRb, Prostate cancer",
author = "Amar Singh and Jones, {Richard F.} and Henry Friedman and Shahendeh Hathir and G. So{\'o}s and Andras Zabo and Haas, {Gabriel P.}",
year = "1999",
month = "11",
language = "English",
volume = "19",
pages = "5415--5417",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers

AU - Singh, Amar

AU - Jones, Richard F.

AU - Friedman, Henry

AU - Hathir, Shahendeh

AU - Soós, G.

AU - Zabo, Andras

AU - Haas, Gabriel P.

PY - 1999/11

Y1 - 1999/11

N2 - Evidence has been presented that tumor suppressor genes p53 and Rb play a crucial role in the development of both human prostate and bladder cancer. Patients with either cancer are at an increased risk for developing the other malignancy as compared to the general population. The purpose of the present study was to investigate whether there is abnormal expression of these two suppressor proteins in both the bladder and prostate cancers of the same patient. The expression of p53 and pRb in bladder and prostate cancer specimens obtained from 15 patients having both cancers was studied using immunohistochemical staining with antibodies against these proteins. The expression of p53 and pRb in both bladder and prostate cancers of the same patient was congruent in 8 of 15 cases (53%) for p53 and 9 of 15 cases (60%) for pRb. The significance of these findings warrants further investigations.

AB - Evidence has been presented that tumor suppressor genes p53 and Rb play a crucial role in the development of both human prostate and bladder cancer. Patients with either cancer are at an increased risk for developing the other malignancy as compared to the general population. The purpose of the present study was to investigate whether there is abnormal expression of these two suppressor proteins in both the bladder and prostate cancers of the same patient. The expression of p53 and pRb in bladder and prostate cancer specimens obtained from 15 patients having both cancers was studied using immunohistochemical staining with antibodies against these proteins. The expression of p53 and pRb in both bladder and prostate cancers of the same patient was congruent in 8 of 15 cases (53%) for p53 and 9 of 15 cases (60%) for pRb. The significance of these findings warrants further investigations.

KW - Bladder cancer

KW - p53

KW - pRb

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0033389843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033389843&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 5415

EP - 5417

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -